✦ LIBER ✦

Biological heterogeneity of er-positive breast cancers in the post-menopausal population

✍ Scribed by Sylvie Romain; Olivier Chinot; Olivier Guirou; Marc Soullière; Pierre-Marie Martin

Publisher: John Wiley and Sons
Year: 1994
Tongue: French
Weight: 370 KB
Volume: 59
Category: Article
ISSN: 0020-7136
DOI: 10.1002/ijc.2910590105

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The cognitive effects of chemotherapy in

The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study

✍ Felice A. Tager; Paula S. McKinley; Freya R. Schnabel; Mahmoud El-Tamer; Ying Ke 📂 Article 📅 2009 🏛 Springer US 🌐 English ⚖ 230 KB

The combination of letrozole and trastuz

The combination of letrozole and trastuzumab as first or second-line biological therapy produces durable responses in a subset of HER2 positive and ER positive advanced breast cancers

✍ P. Kelly Marcom; Claudine Isaacs; Lyndsay Harris; Zee Wang Wong; Aruna Kommarred 📂 Article 📅 2006 🏛 Springer US 🌐 English ⚖ 144 KB

Erratum to: The cognitive effects of che

Erratum to: The cognitive effects of chemotherapy in post-menopausal breast cancer patients: a controlled longitudinal study

✍ Felice A. Tager; Paula S. McKinley; Freya R. Schnabel; Mahmoud El-Tamer; Ying Ke 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 119 KB

Gene expression profiling of response to

Gene expression profiling of response to mTOR inhibitor everolimus in pre-operatively treated post-menopausal women with oestrogen receptor-positive breast cancer

✍ Vicky S. Sabine; Andrew H. Sims; E. Jane Macaskill; Lorna Renshaw; Jeremy S. Tho 📂 Article 📅 2010 🏛 Springer US 🌐 English ⚖ 566 KB

Exemestane as primary systemic treatment

Exemestane as primary systemic treatment for hormone receptor positive post-menopausal breast cancer patients: a phase II trial of the Austrian Breast and Colorectal Cancer Study Group (ABCSG-17)

✍ Brigitte Mlineritsch; Christoph Tausch; Christian Singer; Gero Luschin-Ebengreut 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 267 KB

Estrogen-induced interaction between KLF

Estrogen-induced interaction between KLF5 and estrogen receptor (ER) suppresses the function of ER in ER-positive breast cancer cells

✍ Peng Guo; Xue-Yuan Dong; Ke-Wen Zhao; Xiaodong Sun; Qunna Li; Jin-Tang Dong 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 368 KB

## Abstract Kruppel‐like factor 5 (KLF5) is implicated in human breast cancer by frequent genomic deletion and expressional deregulation, but the molecular mechanisms by which KLF5 affects breast tumorigenesis are still unknown. This study was conducted to examine whether and how KLF5 affects the f